Financing Health Care Delivery

Literature Cited

1. Abaluck J, Gruber J. 2011. Choice inconsistencies among the elderly: evidence from plan choice in the Medicare Part D program. Am. Econ. Rev. 101:41180–1210
   [Google Scholar]
2. Abaluck J, Gruber J. 2016a. Evolving choice inconsistencies in choice of prescription drug insurance. Am. Econ. Rev. 106:82145–84
   [Google Scholar]
3. Abaluck J, Gruber J. 2016b. Choice inconsistencies among the elderly: evidence from plan choice in the Medicare Part D program: Reply. Am. Econ. Rev. 106:123962–87
   [Google Scholar]
4. Abaluck J, Gruber J. 2022. When less is more: improving choices by limiting choices in health insurance markets. Rev. Econ. Stud. In press. https://doi.org/10.1093/restud/rdac050
   [Crossref] [Google Scholar]
5. Baicker K, Mullainathan S, Schwartzstein J. 2015. Behavioral hazard in health insurance. Q. J. Econ. 130:41623–67
   [Google Scholar]
6. Barua B, Ren F. 2015. Leaving Canada for medical care, 2015. Fraser Res. Bull., March
   [Google Scholar]
7. Bhargava S, Loewenstein G, Sydnor J. 2017. Choose to lose: health plan choices from a menu with dominated options. Q. J. Econ. 132:31319–72
   [Google Scholar]
8. Blumberg LJ, Karpman M, Buettgens M, Solleveld P. 2016. Who are the remaining uninsured, and what do their characteristics tell us about how to reach them? Rep., Urban Inst. Washington, DC: http://www.urban.org/sites/default/files/publication/79051/2000691-Who-Are-The-Remaining-Uninsured-And-What-Do-Their-Characteristics-Tell-Us-About_How-To_Reach_Them.pdf
9. Brandt J, Shearer B, Morgan SG. 2018. Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare. J. Pharm. Policy Pract. 11:28
   [Google Scholar]
10. Browne MJ. 1992. Evidence of adverse selection in the individual health insurance market. J. Risk Insur. 59:113–33
    [Google Scholar]
11. Chandra A, Flack E, Obermeyer Z. 2021. The health costs of cost-sharing NBER Work. Pap. 28439. https://www.nber.org/papers/w28439
12. Chandra A, Gruber J, McKnight R. 2010. Patient cost-sharing and hospitalization offsets in the elderly. Am. Econ. Rev. 100:1193–213
    [Google Scholar]
13. CIHI (Can. Inst. Health Inf.) 2021. National health expenditure trends. Can. Inst. Health Inf. Ottawa, Can.: accessed on July 5, 2022. https://www.cihi.ca/en/national-health-expenditure-trends
14. Clemens JD, Gottlieb J. 2017. In the shadow of a giant: Medicare's influence on private physician payments. J. Political Econ. 125:11–39
    [Google Scholar]
15. Conti RM, Gruber J, Ollendorf DA, Neumann PJ. 2020. Valuing rare pediatric drugs: an economics perspective NBER Work. Pap. 27978. https://www.nber.org/papers/w27978
16. Cooper Z, Craig S, Gaynor M, Van Reenen J 2019. The price ain't right? Hospital prices and health spending on the privately insured. Q. J. Econ. 134:151–107
    [Google Scholar]
17. Coulam RF, Gaumer GL. 1992. Medicare's prospective payment system: a critical appraisal. Health Care Financ. Rev. 1991:Suppl45–77
    [Google Scholar]
18. Cutler DM. 2020. Reducing administrative costs in US health care. Brookings Mar. 10. https://www.brookings.edu/research/reducing-administrative-costs-in-u-s-health-care/
    [Google Scholar]
19. Dafny L, Duggan M, Ramanarayanan S. 2012. Paying a premium on your premium? Consolidation in the US health insurance industry. Am. Econ. Rev. 102:21161–85
    [Google Scholar]
20. Decker SL. 2012. In 2011 nearly one-third of physicians said they would not accept new Medicaid patients, but rising fees may help. Health Aff 31:81673–79
    [Google Scholar]
21. Devlin A. 2022. Estimating volume responses to Medicare reimbursement changes Work. Pap., Mass. Inst. Technol. Cambridge, Mass:.
22. Duffin J. 2011. The impact of single-payer health care on physician income in Canada, 1850–2005. Am. J. Public Health 101:71198–1208
    [Google Scholar]
23. Duggan M, Gruber J, Vabson B. 2018. The consequences of health care privatization: evidence from Medicare Advantage exits. Am. Econ. J. Econ. Policy 10:1153–86
    [Google Scholar]
24. Duggan M, Starc A, Vabson B. 2016. Who benefits when the government pays more? Pass-through in the Medicare Advantage program. J. Public Econ. 141:50–67
    [Google Scholar]
25. Einav L, Finkelstein A. 2011. Selection in insurance markets: theory and empirics in pictures. J. Econ. Perspect. 25:1115–38
    [Google Scholar]
26. Einav L, Finkelstein A, Mahoney N. 2021. The IO of selection markets NBER Work. Pap. 29039. https://doi.org/10.3386/w29039
    [Crossref]
27. Feinstein C. 2019. What I learned as a Canadian reporting on healthcare in America—and what Americans can learn from Canada. Business Insider Nov. 22. https://www.businessinsider.com/american-misconceptions-about-canadian-healthcare-2019-11
    [Google Scholar]
28. Feldstein M. 1973. The welfare loss of excess health insurance. J. Political Econ. 81:251–80
    [Google Scholar]
29. Feldstein M, Gruber J. 1995. A major risk approach to health insurance reform. Tax Policy Econ 9:103–30
    [Google Scholar]
30. Forbes. 2008. U.S. hospitals worth the trip. Forbes May 29. https://www.forbes.com/2008/05/25/health-hospitals-care-forbeslife-cx_avd_outsourcing08_0529healthoutsourcing.html?sh=5ab4469552e1
    [Google Scholar]
31. Frakes M, Gruber J. 2020. Defensive medicine and obstetric practices: evidence from the military health system. . J. Empir. Legal Stud. 17:14–37
    [Google Scholar]
32. Frakt A. 2014. Half of medical treatments of unknown effectiveness. The Incidental Economist Jan. 16. https://theincidentaleconomist.com/wordpress/half-of-medical-treatments-of-unknown-effectiveness/
    [Google Scholar]
33. Geruso M, Layton TJ. 2017. Selection in health insurance markets and its policy remedies. J. Econ. Perspect. 31:423–50
    [Google Scholar]
34. Gruber J. 2008. Covering the uninsured in the United States. J. Econ. Lit. 46:3571–606
    [Google Scholar]
35. Gruber J. 2022. Public Finance and Public Policy New York: Macmillan Learning. , 7th ed..
36. Gruber J, Handel BR, Kina SH, Kolstad JT. 2020. Managing intelligence: skilled experts and AI in markets for complex products NBER Work. Pap. 27038. https://www.nber.org/papers/w27038
37. Gruber J, Owings M. 1996. Physician financial incentives and cesarean section delivery. RAND J. Econ. 27:199–123
    [Google Scholar]
38. Guardado JR, Emmons DW, Kane CK. 2013. The price effects of a large merger of health insurers: a case study of UnitedHealth-Sierra. Health Manag. Policy Innov. 1:316–35
    [Google Scholar]
39. Guglielmo A. 2015. Competition and costs in Medicare Advantage Work. Pap., Einaudi Inst. Econ. Finance Rome: https://www.eief.it/files/2015/12/guglielmo-rev.pdf
40. Himmelstein DU, Woodhandler S, Campbell T. 2020. Correction: Health care administrative costs in the United States and Canada, 2017. Ann. Intern. Med. 173:5415
    [Google Scholar]
41. Hirth RA, Gibson TB, Levy HG, Smith JA, Calónico S, Das A. 2015. New evidence on the persistence of health spending. Med. Care Res. Rev. 72:3277–97
    [Google Scholar]
42. Ketcham J, Kuminoff N, Power C. 2016. Rejoinder to Abaluck and Gruber SSRN Work. Pap. 2884875. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2884875
43. KFF (Kaiser Fam. Found.) 2020. 2020 Employer Health Benefits Survey Rep., KFF San Francisco: https://www.kff.org/health-costs/report/2020-employer-health-benefits-survey
44. Liu S, Chollet D. 2006. Price and income elasticity of the demand for health insurance and health care services: a critical review of the literature Rep., Mathematica Policy Res. Washington, DC: https://www.mathematica.org/publications/price-and-income-elasticity-of-the-demand-for-health-insurance-and-health-care-services
45. Lo AW, Thakor RT. 2022. Financing biomedical innovation. Annu. Rev. Financ. Econ. 14:231–70
    [Google Scholar]
46. McGuire TG, Pauly MV. 1991. Physician response to fee changes with multiple payers. J. Health Econ. 10:4385–410
    [Google Scholar]
47. McWilliams JM, Hsu J, Newhouse JP. 2012. New risk-adjustment system was associated with reduced favorable selection in Medicare advantage. Health Aff. 31:122630–40
    [Google Scholar]
48. Medicare 2021. Part B costs. Medicare.gov. https://www.medicare.gov/your-medicare-costs/part-b-costs
    [Google Scholar]
49. Mitchell EM. 2021. Concentration of healthcare expenditures and selected characteristics of high spenders, U.S. civilian noninstitutionalized population, 2018 Stat. Brief 533, Med. Expend. Panel Surv., Agency Healthc. Res. Qual. Rockville, Md: https://meps.ahrq.gov/data_files/publications/st533/stat533.shtml
50. Morid MA, Kawamoto K, Ault T, Dorius J, Abdelrahman S. 2017. Supervised learning methods for predicting healthcare costs: systematic literature review and empirical evaluation. AMIA Annu. Symp. Proc. 2017:1312–21
    [Google Scholar]
51. Newhouse JP. 1993. Free for All? Lessons from the RAND Health Insurance Experiment Cambridge, MA: Harvard Univ. Press
52. OECD (Organ. Econ. Coop. Dev.) 2019a. Health expenditure and financing OECD Paris: retrieved on July 5, 2022. https://stats.oecd.org/Index.aspx?DataSetCode=SHA
53. OECD (Organ. Econ. Coop. Dev.) 2019b. Figure 6.18, thirty-day mortality after admission to hospital for AMI based on unlinked data, 2007 and 2017. Health at a Glance 2019: OECD Indicators Paris: OECD https://doi.org/10.1787/888934016284
    [Crossref] [Google Scholar]
54. OECD (Organ. Econ. Coop. Dev.) 2020. Intensive care beds capacity OECD Paris: retrieved on July 5, 2022. https://www.oecd.org/coronavirus/en/data-insights/intensive-care-beds-capacity
55. O'Neill J, O'Neill D 2007. Health status, health care and inequality: Canada versus the U.S. NBER Work. Pap. 13429. https://doi.org/10.3386/w13429
    [Crossref]
56. Pendzialek JB, Simic D, Stock S. 2016. Differences in price elasticities of demand for health insurance: a systematic review. Eur. J. Health Econ. 17:5–21
    [Google Scholar]
57. Pinkovskiy ML. 2020. The impact of the managed care backlash on health care spending. RAND J. Econ. 51:159–108
    [Google Scholar]
58. Placona AM, King R, Wang F. 2018. Longitudinal clustering of high-cost patients’ spend trajectories: delineating individual behaviors from aggregate trends. AMIA Annu. Symp. Proc. 2018:907–15
    [Google Scholar]
59. Ringel JS, Hosek SD, Vollaard BA, Mahnovski S. 2002. The Elasticity of Demand for Health Care: A Review of the Literature and Its Application to the Military Health System Santa Monica, CA: RAND Corp.
60. Rothschild M, Stiglitz J. 1976. Equilibrium in competitive insurance markets: an essay on the economics of imperfect information. Q. J. Econ. 90:4629–49
    [Google Scholar]
61. Sanger-Katz M. 2020. They want it to be secret: How a common blood test can cost $11 or almost $1,000. New York Times, Apr. 30. https://www.nytimes.com/2019/04/30/upshot/health-care-huge-price-discrepancies.html
    [Google Scholar]
62. Summers LH. 1989. Some simple economics of mandated benefits. Am. Econ. Rev. 79:2177–83
    [Google Scholar]
63. Sutherland J, Crump RT, Repin N, Hellsten E. 2013. Paying for hospital services: a hard look at the options SSRN Work. Pap. 2303809. https://doi.org/10.2139/ssrn.2303809
    [Crossref]
64. Tebaldi P. 2017. Estimating equilibrium in health insurance exchanges: price competition and subsidy design under the ACA. SSRN Work. Pap. 3020103. https://doi.org/10.2139/ssrn.3020103
    [Crossref]
65. Tikkanen R, Osborn R, Mossialos E, Djordjevic A, Wharton GA. 2020. International health care system profiles: Canada. Rep., Commonwealth Fund New York: https://www.commonwealthfund.org/international-health-policy-center/countries/canada
66. Todak A. 2018. US cancer survival rates remain among highest in world. HemOnc Today Jan. 31. https://www.healio.com/news/hematology-oncology/20180131/us-cancer-survival-rates-remain-among-highest-in-world
    [Google Scholar]
67. US House 2011. Health care industry consolidation US House, Comm. Ways Means Health Subcomm., Sept. 9, statement of Martin Gaynor. https://gop-waysandmeans.house.gov/UploadedFiles/Gaynor_Testimony_9-9-11_Final.pdf
68. van Doorslaer E. 2003. Equity in the use of physician visits in OECD countries: Has equal treatment for equal need been achieved?. Measuring Up: Improving Health System Performance in OECD Countries, pp. 225–48 Paris: Organ. Econ. Coop. Dev. https://doi.org/10.1787/9789264195950-13-en
    [Crossref] [Google Scholar]
69. Wolfe PR, Moran DW. 1993. Global budgeting in the OECD countries. Health Care Financ. Rev. 14:355–76
    [Google Scholar]
70. World Bank 2022. Indicator World Bank Washington, DC: retrieved on July 5, 2022. https://data.worldbank.org/indicator/